The studies have not yet been peer-reviewed and were released by J&J prior being printed in a peer-reviewed journal.
A real-life study from South Africa said that the J&J vaccine was 85% effective against hospitalization, even after the omicron variant appeared.“When a booster shot was administered six to nine months after a primary single dose, vaccine effectiveness increased over time from 63 percent at 0-13 days, to 84 percent at 14-27 days and 85 percent at 1-2 months post-boost,” J&J said in a statement.reported.
In cases where the J&J shot was used as a booster in patients who first had Pfizer/BioNTech’s vaccine, they had a 41-fold increase in antibodies and a five-fold increase in T-cells,The Pfizer and J&J results were compared to results in people who got only Pfizer as the three-shot series,After four weeks, the Pfizer and J&J regimen resulted in a 17-fold increase in antibodies and a 1.4-fold increase in T-cells.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Studies indicate J&J Covid-19 vaccine booster protects people against severe illness from Omicron variantTwo reports released Thursday show that people who get booster doses of Johnson & Johnson's Janssen vaccine are well protected against severe disease and hospitalization from the Omicron variant of coronavirus, the company said.
Leer más »
J&J's COVID-19 vaccine booster was 85% effective against hospitalization, in South Africa studyJohnson & Johnson undefined said Thursday that a South African Phase 3 study showed that its a booster shot of its COVID-19 vaccine was 85% effective in...
Leer más »
J&J booster offers strong protection against omicron, study showsJohnson & Johnson's booster provides strong protection against the omicron variant of Covid-19, according to a trial of healthcare workers in South Africa.
Leer más »
Fauci says all indications suggest omicron is less severe than delta, but warns against complacency'All indications point to a lesser severity of omicron versus delta,' said Fauci, President Joe Biden's top health advisor, of the early Covid variant data.
Leer más »
J&J's booster shown effective against Covid hospitalizationBREAKING: Two doses of Johnson & Johnson's Covid-19 vaccine provided up to 85 percent protection against hospitalization from the Omicron variant, researchers in South Africa reported on Thursday
Leer más »
Fauci says U.S. should 'seriously' consider vaccine requirement for domestic flights amid Omicron surgePresident Biden's chief medical adviser says it could be 'another incentive to get more people vaccinated.'
Leer más »